Showing results (61-70 of 475) with videos related to
Sort By:
Pageof 48
British Journal of Clinical Pharmacology|December 12, 2018
Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modellingJennifer E Hibma, Hagop M Kantarjian, Daniel J DeAngelo, et al.Molecular and Cellular Biology|March 18, 2020
MAML1-Dependent Notch-Responsive Genes Exhibit Differing Cofactor Requirements for Transcriptional ActivationJulia M Rogers, Bingqian Guo, Emily D Egan, et al.Histopathology|March 7, 2017
Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissuesJacqueline M Cortazar, Daniel J DeAngelo, Geraldine S Pinkus, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2010
Plasma organochlorine levels and risk of non-Hodgkin lymphoma in the Nurses' Health StudyFrancine Laden, Kimberly A Bertrand, Larisa Altshul, et al.Leukemia & Lymphoma|September 16, 2024
Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidationEvan C Chen, Yael Flamand, Emily Tiao, et al.Structure (London, England : 1993)|April 13, 2011
Evidence for increased exposure of the Notch1 metalloprotease cleavage site upon conversion to an activated conformationKittichoat Tiyanont, Thomas E Wales, Miguel Aste-Amezaga, et al.Plos One|October 13, 2017
The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemiaSung Hee Choi, Eric Severson, Warren S Pear, et al.Blood|May 18, 2018
RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in miceSamuel Y Ng, Leon Brown, Kristen Stevenson, et al.Nature Structural & Molecular Biology|April 3, 2007
Structural basis for autoinhibition of NotchWendy R Gordon, Didem Vardar-Ulu, Gavin Histen, et al.Plos One|May 10, 2019
Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signaturesWaihay J Wong, Michele Baltay, Annaliese Getz, et al.Pageof 48